proscillaridin, 466-06-8

Articles:

PubMed:	Convallatoxin: A new P-glycoprotein substrate.
PubMed:	Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
PubMed:	The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: discovery of an active cardiac glycoside from Urginea maritima.
PubMed:	Interaction of digitalis-like compounds with p-glycoprotein.
PubMed:	Inhibition of DNA topoisomerases I and II by G3 PAMAM-NH2 dendrimer-modified digoxin and proscillaridin A conjugates in a cell free system.
PubMed:	Synthesis and cytotoxic activity of G3 PAMAM-NH(2) dendrimer-modified digoxin and proscillaridin A conjugates in breast cancer cells.
PubMed:	Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts.
PubMed:	Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs.
PubMed:	Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth.
PubMed:	Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells.
PubMed:	Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells.
PubMed:	Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A.
PubMed:	A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure.
PubMed:	Ouabain binding to Na+,K+-ATPase relaxes cell attachment and sends a specific signal (NACos) to the nucleus.
PubMed:	[Separation and purification of an endogenous inhibitor of sodium pump from chansu by thin-layer chromatography and reversed-phase high performance liquid chromatography].
PubMed:	[An elderly case of idiopathic dilatation of the right atrium in which right-sided heart failure was exacerbated by drug-induced bradyarrhythmia].
PubMed:	Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells.
PubMed:	The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity.
PubMed:	Exquisitely small amounts of nonglucocorticoid natural steroids suppress the human allogeneic T-cell response.
PubMed:	Sanguinarine induces K+ outflow from yeast cells expressing mammalian sodium pumps.
PubMed:	Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor.
PubMed:	Scilla maderensis, TLC screening and positive inotropic effect of bulb extracts.
PubMed:	[A case of proscillaridin poisoning].
PubMed:	Proscillaridin A immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure.
PubMed:	A specific binding protein for cardiac glycosides exists in bovine serum.
PubMed:	Bovine adrenals and hypothalamus are a major source of proscillaridin A- and ouabain-immunoreactivities.
PubMed:	Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump.
PubMed:	Proscillaridin A immunoreactivity: a new endogenous cardiac glycoside?
PubMed:	Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound.
PubMed:	Role of endogenous cardiac glycosides in the spontaneously hypertensive rat--antagonism by active immunization.
PubMed:	Uptake and sequestration of ouabain and other cardiac glycosides inDanaus plexippus (Lepidoptera: Danaidae): Evidence for a carrier-mediated process.
PubMed:	About the bufadienolide complex of "red" squill.
PubMed:	Cardiac glycoside-induced elevation of intracellular Na+ ion concentration in human erythrocytes studied by 23Na NMR spectroscopy: relationship between inotropy speed and elevation rate of intracellular Na+ ion concentration.
PubMed:	[Preparation of phenylpropylsilica and its application to high performance liquid chromatographic analysis of proscillaridin].
PubMed:	[Studies on cardiac ingredients of plants. X. Preparation of nitrates of tetrahydroproscillaridin and their pharmacological activities].
PubMed:	[Effects of bufadienolides and some kinds of cardiotonics on guinea pig hearts].
PubMed:	Studies on cardiac ingredients of plants. IX. Chemical transformation of proscillaridin by utilizing its 1,4-cycloadducts as key compounds and biological activities of their derivatives.
PubMed:	Bufadienolides from Urginea maritima sensu strictu.
PubMed:	Studies on cardiac ingredients of plants. VII: Chemical transformation of proscillaridin by means of the Diels-Alder reaction and biological activities of its derivatives.
PubMed:	[Studies on cardiac ingredients of plants. VIII. Preparation of nitrates of proscillaridin and their pharmacological activities].
PubMed:	Cardiotonic drugs inhibit purified mammalian acetylcholinesterase.
PubMed:	Specific anti-digoxin Fab fragments: an available antidote for proscillaridin and scilliroside poisoning?
PubMed:	The bioavailability of methylepoxyproscillaridin (P35): a new semisynthetic cardiac glycoside.
PubMed:	Hemodynamic effect of methylepoxyproscillaridin (P35) in patients with congestive myocardiopathy.
PubMed:	Studies on cardiac ingredients of plants. V. Chemical transformation of proscillaridin and biological activities of derivatives.
PubMed:	Binding of [3H]ouabain to endothelial cells derived from various vascular beds.
PubMed:	[Studies on cardiac ingredients of plants (IV). Effect of reduced proscillaridins on guinea-pig hearts].
PubMed:	Studies on cardiac ingredients of plants. III. Structural confirmation and biological activity of reduced proscillaridins.
PubMed:	Determination of proscillaridin in plasma by radioimmunoassay.
PubMed:	[Potential radiopharmaceutical for adrenal gland scintigraphy. 1. Radioiodination of tyramine derivatives of some derivatives of digitoxigenin and scillarenin].
PubMed:	[Use of a cardiotonic agent in the ventricular pre-excitation syndrome. Report of a case].
PubMed:	A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects.
PubMed:	[Effect of plant glycosides on resistance and capacitance vessels].
PubMed:	Electrophysiological studies of some semisynthetic cardiac glycoside derivatives in isolated papillary muscle of the guinea-pig.
PubMed:	Quantitation of Principal Bufadienolides in Different Cytotypes of Urginea indica.
PubMed:	[Plasma concentration and elimination behavior of the cardiac glycoside meproscillarin in patients with liver cirrhosis].
PubMed:	Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
PubMed:	Pharmacokinetic review of digitalis glycosides.
PubMed:	[Therapy of chronic cardiac insufficiency with cardiac glycosides].
PubMed:	[Evaluation of the practical use of mathematical methods and computer technics for the control of treatment with selected digitalis glycosides].
PubMed:	[Use of mathematical methods and computer technics for monitoring the concentration of digitalis glycosides in the body of patients with symptoms of overdigitalization].
PubMed:	[Problems of glycoside therapy in kidney insufficiency and uremia].
PubMed:	[Threshold of action of meproscillarin following intravenous administration].
PubMed:	[Determination of individual sensitivity threshold to digitalis glycosides in chronic circulatory insufficiency].
PubMed:	[Densitometric determination of proscillaridin A, scillaren A and scilliroside].
PubMed:	[Construction of tables facilitating daily control of treatment with proscillaridin A].
PubMed:	[Meproscillarin in patients with renal failure and concomitant heart failure (author's transl)].
PubMed:	Disposition rate of proscillaridin A in man after multiple oral doses.
PubMed:	[14,15-beta-oxido analog of proscillaridin (HOE 040). A new cardiac glycoside with low arrhythmic activity and greater absorption ratio].
PubMed:	[Effect of proscillaridin on adenosine triphosphatase in kidney tissue in the rat. Electron microscopy demonstration and significance for calcium metabolism].
PubMed:	[Effect of proscillaridin on specific adenosine triphosphatases in heart muscle of rats. Electron optical demonstration and significance for calcium metabolism].
PubMed:	[Modern cardiac glycoside therapy].
PubMed:	[Studies on the disposition of meproscillarin in rat and dog (author's transl)].
PubMed:	[Studies on extracardiac effects of the cardiac glycoside meproscillarin in animal experiments (author's transl)].
PubMed:	[Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)].
PubMed:	[Cardiac glycoside receptor affinity and (Na++K+)-ATPase inhibition of digitoxin, digoxin, methyldigoxin, strophanthin, proscillaridin, and meproscillarin. Measurements on isolated human cardiac cell membranes].
PubMed:	Contribution to the biochemical characterization of cardiac glycosides concerning their influence on ATP-ases.
PubMed:	[Effect of proscillaridin-4'-methylether on pressure rise velocity in the left ventricle of patients with coronary heart disease (author's transl)].
PubMed:	Proscillaridin activity in portal and peripheral venous blood after oral administration to man.
PubMed:	Biliary excretion and enterochepatic recycling of proscillaridin A after oral adminstration to man.
PubMed:	Stability in vitro of methylproscillaridin.
PubMed:	Activities of proscillaridin A in thoracic duct lymph after single oral doses in man.
PubMed:	[Echocardiography during the therapy of cardiovascular diseases].
PubMed:	[Comparative studies of action in cats of intraintestinally administered digoxin, proscillardin and K- strophantoside].
PubMed:	[Influence of high intravenous doses of D-penicillamine on toxic actions of cardiac glycosides in the guinea pig. Short communication (author's transl)].
PubMed:	On the absorption of proscillaridin A after single oral doses to normal and achlorhydric subjects.
PubMed:	Proscillaridin A yield from squill bulbs.
PubMed:	[Trial of a combination of proscillaridin A, thioridazine and Cori ester in the ambulatory treatment of some cardiopathies, especially senile types].
PubMed:	[Echocardiographic evaluation of left ventricular function during therapy with cardiovascularly effective drugs].
PubMed:	Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man.
PubMed:	[Enteral availability and therapeutic activity of proscillaridin-4'-methyl ether (author's transl)].
PubMed:	Plasma concentrations during repeated intravenous and oral methyl-proscillaridin application in man.
PubMed:	[Investigations on the Stability of Proscillaridine, Proscillaridine-3'-methylether and Proscillaridine-4'-methylether in Artificial Gastric and Intestinal Fluids (author's transl)].
PubMed:	Excretion of methylproscillaridin in patients with a biliary fistula.
PubMed:	[Standardized prescription glycoside: results of prescription analysis and clinical observations (glycoside intoxication)].
PubMed:	Multiclinical open studies on the effect of beta-methyldigoxin on congestive heart failure with atrial fibrillation.
PubMed:	Metabolism and excretion of methylproscillaridin by man.
PubMed:	On the pharmacokinetics of proscillaridin A in man.
PubMed:	[Relationship between binding to the myocardium and effects of proscillaridin on isolated perfused heart of the guinea pig].
PubMed:	In vitro stability of proscillaridin A.
PubMed:	[Enteral availability and suggested dosages for methyl proscillaridin in decompensated heart patients].
PubMed:	Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
PubMed:	[Effect and plasma level of methylproscillaridin and beta-acetyldigitoxin following long term administration in man].
PubMed:	Effect of oral charcoal on plasma levels of intravenous methyl proscillaridin.
PubMed:	[Plasma concentrations and elimination of methyl proscillaridin in renal failure (author's transl)].
PubMed:	[Plasma levels, elimination and cumulation of proscillaridin in renal failure (author's transl)].
PubMed:	A study on timed intracellular localization and distribution of tritiated digitoxin and proscillaridin A in the myocardial cells by electron microscopic autoradiography.
PubMed:	[Studies on direct effects of proscillaridin A on the electrolyte excretion and transport ATPase in dog kidneys (author's transl)].
PubMed:	The reactivation of the proscillaridin-inhibited membrane ATPase by specific antibodies.
PubMed:	[Effect of proscillaridin on active cation transport across human red cell membrane (author's transl)].
PubMed:	Proceedings: Studies on pharmacokinetics of proscillaridin-4'-methyl ether in man.
PubMed:	[Plasma levels and electrocardiogram after intravenous administration of proscillaridin and digoxin].
PubMed:	Plasma levels after a single oral dose of proscillaridin.
PubMed:	Characterization and specificity of proscillaridin antibodies.
PubMed:	A comparison of the cardiovascular effects of proscillaridin and ouabain in anaesthetised dogs.
PubMed:	[Cardiotonic effects of proscillaridin A].
PubMed:	A quantitative comparison of the cardiac actions of peruvoside with those of G-strophanthin and proscillaridin.
PubMed:	Species and ionic influences on the accumulation of digitalis glycosides by isolated perfused hearts.
PubMed:	[Combination of proscillaridin A and secobarbital. Clinical report].
PubMed:	[Practical aspects of treatment of senile cardiopathies with a combination of proscillaridin A, thioridazine and Cori ester].
PubMed:	The hemodynamic response to digoxin and proscillaridin during rest and exercise in patients with a fixed rate artificial pacemaker.
PubMed:	Protection by catatoxic steroids and related compounds against proscillaridin intoxication.
PubMed:	[Talusin (proscillaridin)--once more].
PubMed:	Pharmacological and electrophysiological actions of proscillaridin A. The mechanism of bigeminal rhythm induced by its toxic dosage studied by the change of the transmembrane action potential.
PubMed:	[Effects of proscillaridin A on the dynamic values of cardiac revolution, measured with the polygraphic method in patients with myocardial infarct in the acute phase].
PubMed:	[Conformation of rhamnose in proscillaridin].
PubMed:	[Cardiovascular effect of a cardiac glycoside, proscillaridin A].
PubMed:	[Proscillaridin carbonates].
PubMed:	[Clinical trial of proscillaridin A].
PubMed:	[Methyl ether of proscillaridin].
PubMed:	[Study of the activity of a cardioactive glucoside, proscillaridin A, in ambulatory patients].
PubMed:	[Behavior of gastric secretion after administration of a single dose of Proscillaridin A. Statistical and clinical findings].
PubMed:	[Effect of cardiac glycosides on the duration of systole. A comparison between proscillaridin and strophanthin].
PubMed:	[Acetates of proscillaridin].
PubMed:	[Clinical experience in the use of proscillaridin A in cardiac patients with tubercular bronchopneumopathy].
PubMed:	[Therapeutic trial of an association of theophylline and proscillaridin A in the treatment of cor pulmonale and of some decompensated heart diseases].
PubMed:	Clinical studies on proscillaridin a new squill glycoside.
PubMed:	[Acyl and alkyl derivatives of proscillaridin].
PubMed:	[On some aspects of occupational pathology in workers engaged in the manufacture of proscillaridin A].
PubMed:	[Clinical evaluation of the association of proscillaridin and beta-hydroxy-ethyl-theophylline in the treatment of cardiac insufficiency].
PubMed:	[Clinical and physiopathological observations on the treatment of chronic cor pulmonale with an association of theophylline and proscillaridin A].
PubMed:	[Clinical and experimental studies on the effect of proscillaridin A].
PubMed:	[Pharmacology of isopropylidene-proscillaridin].
PubMed:	Comparative cardiovascular effects and metabolism of proscillaridin A and of digoxin.
PubMed:	[Metabolic turnover and effect of cardiac glycosides. I. Determination of blood levels and of the ventricular ejection index and of R-I time derivated from apex cardiogram after intravenous injection of acetyl-digitoxin or proscillaridin A-H3 in normal subjects].
PubMed:	[Influencing the cardiotonic effect of proscillaridin by verapamil].
PubMed:	[Dynamics of the total left ventricular systole under the influence of cardiac glycosides with particular reference to proscillaridin A].
PubMed:	Effect of spironolactone and norbolethone on the toxicity of digitalis compounds in the rat.
PubMed:	Comparative effects of digoxin and proscillaridin in the heart-lung preparation.
PubMed:	[Contribution to the quantitative and qual-itative study on the glycoside proscillaridin].
PubMed:	[Experiences with the clinical use of proscillaridin A].
PubMed:	The uptake and release of proscillaridin-3H by several tissues of the guinea pig after oral administration.
PubMed:	[Proscillaridin A in the therapy of decompensated heart diseases].
PubMed:	[Clinical observations on the use of a combination of proscillaridin and theophylline in the treatment of the senile heart and chronic cor pulmonale].
PubMed:	[Intravenous proscillaridin A in cardiotonic therapy of the senile heart].
PubMed:	Effects of dimethyl sulfoxide (DMSO) on cardiovascular responses to ouabain, proscillaridin and digitoxin.
PubMed:	[Clinical evaluation of Proscillaridin A, a glycoside of Scilla maritima].
PubMed:	[Clinical experimental studies with the heart glycoside, proscillaridin, with special reference to its enteral resorption rate].
PubMed:	Assessment of contractility following proscillaridin A in dog hearts both normal and pretreated with propranolol.
PubMed:	[Therapeutic experiences with proscillaridin A in decompensated heart diseases].
PubMed:	[Clinical experiences with a squill preparation (proscillaridin A) in oral administration].
PubMed:	[Some clinical observations on the use of a cardiokinetic extract of squill: proscillaridin A. Differences from other more commonly used glycosides].
PubMed:	[Clinical action of a new cardioactive glycoside: proscillaridin A].
PubMed:	[On the effectiveness of proscillaridin A as deduced from the study of cardiac output in patients with myocardiosclerosis].
PubMed:	[The clinical use of a new cardioactive glycoside: proscillaridin A].
PubMed:	[Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
PubMed:	[Therapeutic examination of proscillaridin A].
PubMed:	[The use of proscillaridin A in the therapy of cardiac insufficiency in the aged].
PubMed:	[On the question of standardization of German bulbus Scillae standard and proscillaridin A in guinea pigs].
PubMed:	[On the clinical use of proscillaridin A (Sandoscill)].
PubMed:	[Experiences with the cardiac glycoside Proscillaridin A (Sandoscill)].
PubMed:	[Observations on the use of proscillaridin A in some disorders of cardiac rhythm].
PubMed:	[A year of clinical experience with a new cardio-active glycoside, proscillaridin].
PubMed:	[The use of a new cardioactive glucoside: Proscillaridin A, in the treatment of cardiopathy in the aged].
PubMed:	[Comparative studies on the diuretic effect and acute toxicity of g-strophanthin, scillaren and proscillaridin in dogs].
PubMed:	[Clinical analysis with proscillaridin].
PubMed:	[Comparative hemodynamic effect of proscillaridin A and strophanthin].
PubMed:	Comparative blood pressure and electrocardiographic changes induced by proscillaridin and ouabain.
PubMed:	[Changes of the electrocardiograms of heart disease patients caused by the administration of proscillaridin A].
PubMed:	[Value of the clinical use of proscillaridin A].
PubMed:	[Contribution to the konwledge of some effects of proscillaridin on the cardiovascular system. Electrocardiographic and radiocardiographic research].
PubMed:	[Data on the hospital treatment of heart disease patients with proscillaridin A].
PubMed:	[Clinical experience with a new cardioactive glycoside: Proscillaridin A].
PubMed:	Treatment of chronic right-heart lesions. Proscillaridin for cor pulmonale and the senile heart.
PubMed:	[Clinical use of a new cardioactive glycoside: proscillaridin A].
PubMed:	[Clinical notes on the effect of a new cardiokinetic drug (proscillaridin A)].
PubMed:	[Research on a new cardioactive glycoside in clinical practice: proscillaridin A].
PubMed:	[Clinical observations on the use of a new cardioactive glycoside: proscillaridin A].
PubMed:	[Proscillaridin A in some senile heart diseases. Preliminary clinico-therapeutic observations].
PubMed:	[Study of the therapeutic effect of a cardioactive glycoside extracted from scilla (proscillaridin A), by means of polygraphic investigations].
PubMed:	[Evaluation by the polygraphic method of the cardiokinetic action of a new glycoside isolated from scilla (proscillaridin A)].
PubMed:	[On the therapy of heart insufficiency with the pure glycoside Proscillaridin A].
PubMed:	[Experience with proscillaridin A in cardiac insufficiency].
PubMed:	[Clinical experimentation with a new cardioactive glycoside derived from Scilla: proscillaridin].
PubMed:	[Clinical studies on the cardiotonic effects of proscillaridin A].
PubMed:	[Action of oral proscillaridin treatment in various forms of heart insufficiency].
PubMed:	[Effects of proscillaridin A on the duration of phases of ventricular systole and on normal heart rate].
PubMed:	[Therapeutic experiences with a new cardiac glycoside: proscillaridin A].
PubMed:	[STUDIES ON THE EFFECTIVENESS OF PROSCILLARIDIN A].
PubMed:	[ON PHARMACOLOGY AND THE THERAPEUTIC USE OF PROSCILLARIDIN A].